RPRahel Pearson

Rahel Pearson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rahel Pearson has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Beyond posttraumatic stress disorder diagnosis: How specific trauma symptoms drive long-term disability in veterans.

    by Rahel Pearson, Allison Metts, Marcus G. Wild, Emma P. Harris, Sheila O'BRien, Suzannah K. Creech

    The link between trauma-related symptomatology and psychosocial disability is well-established. However, the extent to which specific PTSD symptom clusters differentially contribute to distinct psychosocial disability domains remains unclear. This study examined these associations, hypothesizing that negative alterations in mood and cognition and hyperarousal symptoms would be the strongest predictors of concurrent and future psychosocial disability. We conducted a secondary analysis of longitudinal data from 332 veterans (30% female) with a range of trauma-related symptom severity, as measured by the PTSD Checklist for DSM-5 (PCL-5; M = 27.6, SD = 20.8). Linear mixed-effects models were used to assess the unique contributions of PTSD symptom clusters to psychosocial disability across six domains-understanding/communication, mobility, self-care, interpersonal relationships, life activities, and social participation-measured four times over 24 months. Across domains, negative alterations in mood and cognition and hyperarousal symptoms emerged as the most consistent predictors of psychosocial disability, with effect sizes ranging from small (β = 0.14) to large (β = 0.53). Avoidance symptoms showed more domain-specific associations, particularly for mobility and social participation. Time effects indicated improvement in several domains, though self-care disability remained stable. PTSD symptoms explained more variance in interpersonal and social functioning than in domains related to physical functioning and self-care. Negative alterations in mood and cognition and hyperarousal symptoms exert disproportionate influence on psychosocial disability, underscoring their importance as treatment targets. Avoidance may contribute to disability in specific life domains, highlighting the need for rehabilitation strategies tailored to both broad and domain-specific impairments in veterans with trauma-related symptomatology. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

  • A qualitative study of digital CBT for veteran depression: Treatment experiences and recommendations for healthcare system integration

    by Rahel Pearson, Joseph Mignogna, Allison Metts, Christopher G. Beevers, Edward P. Post, Suzannah K. Creech

  • Digital interventions targeting the impact of stress on stress-related mental health outcomes in military personnel and veterans: a systematic review

    by Allison Metts, Emma Harris, Nevaeh Martinez, Rahel Pearson, Suzannah K. Creech

    Stressors are prevalent throughout and following military careers and dispose military personnel and veterans to stress-related psychopathology. Most available interventions primarily focus on symptoms, overlooking the predisposing risk factor of stress, and are subject to access barriers. Digital interventions targeting stress can increase access and reduce the incidence of stress-related psychopathology. This systematic review evaluated available research on digital interventions targeting the impact of stress on stress-related mental health outcomes among military personnel and veterans. This systematic review is registered in PROSPERO (ID#masked) and funded by the U.S. Department of Veterans Affairs. Following PRISMA guidelines, three databases (APA PsycInfo, PubMed, PTSDPubs) were systematically searched until September 30, 2025. Inclusion criteria were: samples containing military personnel or veterans; quantitative measures of stress, depression, anxiety, trauma-related distress, or mood as primary measures; digital interventions targeting stress; and peer-reviewed research. Critical appraisal checklists were used to assess the risk of bias. Data were synthesized according to the Joanna Briggs Institute Manual for Systematic Reviews. Of the 15 studies that met inclusion criteria, 13 had acceptable data quality (at least 70% on critical appraisal checklists). Samples were predominantly White (100%), male (86.7%), and veteran-only (66.7%). Posttraumatic stress disorder was the most common type of mental health disorder characterizing samples (40%). Digital interventions were delivered in app (60%), web-based (33.3%), and task-based (6.7%) formats. Two studies examined only feasibility and acceptability of the interventions. Of the 13 studies that examined the clinical impact of digital interventions on stress-related mental health outcomes, only six reduced stress-related mental health outcomes compared to a control condition. Monitoring stress was the most common feature of digital interventions, followed by a variety of skills-based content (e.g., breathing techniques). Only two studies examined just-in-time interventions that prompted an intervention in response to stress detection. Digital interventions targeting stress among veterans and miliary personnel are limited in number, diverse in approach, and offer limited evidence for efficacy across stress-related mental health outcomes. Nevertheless, existing research provides a strong foundation for future stress intervention development, including just-in-time interventions, to facilitate a more adaptive response to stressors and increase resilience.


  • Open Access

    Deprexis for Veteran Depression: Feasibility, Acceptability, and Preliminary Efficacy in an Open-Label Pilot Trial (Preprint)

    by Rahel Pearson, Emma Harris, Allison Metts, Christopher Graham Beevers, Paul N. Pfeiffer, Suzannah Creech

    Background: Depression carries the highest burden of mental health–related disability in the United States. Approximately 13% of military veterans report elevated rates of depression. Despite the availability of evidence-based treatments for depression, nearly 50% of veterans in need of mental health care remain untreated. Internet-based interventions show promise in reducing this gap; however, there are currently no standard self-guided internet-based interventions for depressive symptoms in veterans. Deprexis is one such intervention that leverages cognitive behavioral therapy to target depressive symptoms. Objective: This pilot study evaluated the feasibility, acceptability, and preliminary effectiveness of Deprexis, a fully self-guided internet-based intervention for depression, in US military veterans with mild to severe depressive symptoms. Methods: This open-label pilot trial recruited 19 veterans with mild to severe depression (mean age 55.5, SD 8.2 y; baseline Quick Inventory of Depressive Symptomatology—Self-Report [QIDS-SR]: mean 16.2, SD 4.1) for an 8-week course of Deprexis, with self-report assessments at baseline, posttreatment (8 wk), and follow-up (16 wk). Primary outcomes included depressive symptoms (QIDS-SR), functional disability (World Health Organization Disability Assessment Schedule 2.0), and symptom-related disability (Sheehan Disability Scale). Feasibility was assessed through recruitment and retention rates, and acceptability was measured using validated questionnaires (Credibility and Expectancy Questionnaire and Client Satisfaction Questionnaire). Multilevel models examined change over time, with effect sizes calculated using pooled SDs from unconditional models. Results: Recruitment and retention targets were met, with 15 out of 19 (79%) participants meeting the adherence criteria (ie, ≥60 min of active program use). Of these, 14 participants completed posttreatment questionnaires and were included in the completer analyses. The program received a positive acceptability rating: of the 18 participants who completed follow-up assessments, 78% (n=14) rated services as good or excellent and 72% (n=13) were satisfied with the amount of help received. No safety concerns were reported. Among completers (n=14), QIDS-SR scores decreased from baseline to posttreatment (estimate −2.22, SE 1.44; P =.14; d =−0.54, 95% CI −1.07 to 0.13) and follow-up (estimate −2.85, SE 1.19; P =.02; d =−0.70, 95% CI −1.21 to −0.08) with moderate-to-large effect sizes. Effect sizes were similar in the total sample. Functioning (World Health Organization Disability Assessment Schedule 2.0) improved among completers at follow-up (estimate −8.09, SE 3.80; P =.045; d =−0.41, 95% CI −0.96 to −0.05). Disability (Sheehan Disability Scale) did not significantly improve from baseline to posttreatment or follow-up. Conclusions: This pilot trial demonstrates that Deprexis is feasible and acceptable for veterans with mild to severe depression, with preliminary evidence of effectiveness for depressive symptoms. The delayed emergence of functional improvements and sustained gains at follow-up support the potential of this scalable intervention. The results provide a strong foundation for the ongoing randomized controlled trial.

  • Open Access

    A Pilot Evaluation of Deprexis: Feasibility, Acceptability, and Preliminary Efficacy in a Veteran Sample (Preprint)

    by Rahel Pearson, Emma Harris, Allison Metts, Christopher Graham Beevers, Paul N. Pfeiffer, Suzannah Creech

    UNSTRUCTURED Objective: This pilot study evaluated the feasibility, acceptability, and preliminary effectiveness of Deprexis, a fully self-guided internet-based intervention for depression, in U.S. military Veterans with mild to moderate depressive symptoms. Methods: This open-label pilot trial recruited 19 Veterans with mild to moderate depression (QIDS-SR scores 6-20) for an 8-week course of Deprexis, with assessments at baseline, post-treatment (8 weeks), and follow-up (16 weeks). Primary outcomes included depressive symptoms (QIDS-SR), functional disability (WHODAS-2.0), and symptom-related disability (SDS). Feasibility was assessed through recruitment and retention rates, while acceptability was measured using the Credibility/Expectancy Questionnaire and Client Satisfaction Questionnaire. Multilevel models examined change over time, with effect sizes calculated using pooled standard deviations from unconditional models. Results: Recruitment and retention targets were met, with 79% of participants meeting adherence criteria (i.e., >= 60 minutes of active program use). The program was perceived as credible and received positive acceptability rating, with no safety concerns reported. Depression scores showed significant improvement from baseline to post-treatment (d=-0.47-d=-0.53) and follow-up (d=-0.70 - d=-0.77) with moderate-to-large effect sizes in both the total sample and completers. Functioning improvements were observed among completers at follow-up (d = -0.41). Conclusions: This pilot trial demonstrates that Deprexis is feasible and acceptable for Veterans with mild to moderate depression, with preliminary evidence of effectiveness for depressive symptoms. The delayed emergence of functional improvements and sustained gains at follow-up support the potential of this scalable intervention. Results provide a strong foundation for the planned randomized controlled trial.

  • Open Access

    Corrigendum to “Protocol for a randomized clinical trial of strength at home parents: A trauma informed parenting intervention for veterans” [Contempor. Clin. Trials Commun. 41 (2024) 101363]

    by Rahel Pearson, Paul J. Rathouz, Corina Mendoza, Emma Harris, Allison Metts, Kathryn Roe, Justin Benzer, Casey Taft, Suzannah K. Creech

  • Emotion Dysregulation, Mindfulness, Self-Compassion, and Values Engagement in US Post-9/11 Veterans

    by Allison Metts, Marcus G. Wild, Rahel Pearson, Alison Krauss, Corina Mendoza, Sheila F. O’bRien, Suzannah K. Creech

  • Open Access

    The Evaluation of a Web-Based Intervention (Deprexis) to Decrease Depression and Restore Functioning in Veterans: Protocol for a Randomized Controlled Trial

    by Rahel Pearson, Christopher G Beevers, Joseph Mignogna, Justin Benzer, Paul N Pfeiffer, Edward Post, Suzannah K Creech

    Background: Depressive symptoms are common in veterans, and the presence of these symptoms increases disability as well as suicidal thoughts and behaviors. However, there is evidence that these symptoms often go untreated. Intervening before symptoms become severe and entrenched is related to better long-term outcomes, including improved functioning and less disease chronicity. Computer-delivered interventions may be especially appropriate for those veterans with mild to moderate depressive symptoms, because these interventions can require fewer resources and have lower barriers to access and thus have potential for wider reach. Despite this potential, there is a dearth of research examining computerized interventions for depressive symptoms in veteran samples. Objective: The aim of this study is to evaluate the efficacy of Deprexis (GAIA AG), a computerized intervention for depressive symptoms and related functional impairment. Methods: Veterans will be recruited through the US Department of Veterans Affairs electronic medical record and through primary care and specialty clinics. First, qualitative interviews will be completed with a small subset of veterans (n=16-20) to assess the acceptability of treatment procedures. Next, veterans (n=132) with mild to moderate depressive symptoms will be randomly assigned to the fully automated Deprexis intervention or a treatment-as-usual control group. The primary outcomes will be self-reported depressive symptoms and various dimensions of psychosocial functioning. Results: This project was funded in May 2024, and data collection will be conducted between October 2024 and April 2029. Overall, 4 participants have been recruited as of the submission of the manuscript, and data analysis is expected in June 2029, with initial results expected in November 2029. Conclusions: This study will provide initial evidence for the efficacy of self-guided, computerized interventions for depressive symptoms and functional impairment in veterans. If effective, these types of interventions could improve veteran access to low-resource psychosocial treatments. Trial Registration: ClinicalTrials.gov NCT06217198; https://www.clinicaltrials.gov/study/NCT06217198 International Registered Report Identifier (IRRID): PRR1-10.2196/59119


  • Open Access

    Protocol for a randomized clinical trial of strength at home parents: A trauma informed parenting intervention for veterans

    by Rahel Pearson, Paul J. Rathouz, Corina Mendoza, Emma Harris, Allison Metts, Kathryn Roe, Justin Benzer, Casey Taft, Suzannah K. Creech

  • Open Access

    The Evaluation of a Web-Based Intervention (Deprexis) to Decrease Depression and Restore Functioning in Veterans: Protocol for a Randomized Controlled Trial (Preprint)

    by Rahel Pearson, Christopher G Beevers, Joseph Mignogna, Justin Benzer, Paul N Pfeiffer, Edward Post, Suzannah K Creech

    BACKGROUND Depressive symptoms are common in veterans, and the presence of these symptoms increases disability as well as suicidal thoughts and behaviors. However, there is evidence that these symptoms often go untreated. Intervening before symptoms become severe and entrenched is related to better long-term outcomes, including improved functioning and less disease chronicity. Computer-delivered interventions may be especially appropriate for those veterans with mild to moderate depressive symptoms, because these interventions can require fewer resources and have lower barriers to access and thus have potential for wider reach. Despite this potential, there is a dearth of research examining computerized interventions for depressive symptoms in veteran samples. OBJECTIVE The aim of this study is to evaluate the efficacy of Deprexis (GAIA AG), a computerized intervention for depressive symptoms and related functional impairment. METHODS Veterans will be recruited through the US Department of Veterans Affairs electronic medical record and through primary care and specialty clinics. First, qualitative interviews will be completed with a small subset of veterans (n=16-20) to assess the acceptability of treatment procedures. Next, veterans (n=132) with mild to moderate depressive symptoms will be randomly assigned to the fully automated Deprexis intervention or a treatment-as-usual control group. The primary outcomes will be self-reported depressive symptoms and various dimensions of psychosocial functioning. RESULTS This project was funded in May 2024, and data collection will be conducted between October 2024 and April 2029. Overall, 4 participants have been recruited as of the submission of the manuscript, and data analysis is expected in June 2029, with initial results expected in November 2029. CONCLUSIONS This study will provide initial evidence for the efficacy of self-guided, computerized interventions for depressive symptoms and functional impairment in veterans. If effective, these types of interventions could improve veteran access to low-resource psychosocial treatments. CLINICALTRIAL ClinicalTrials.gov NCT06217198; https://www.clinicaltrials.gov/study/NCT06217198 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/59119